Internal Medicine, Hematology & Oncology · Omaha, NE
NPI
1548219553
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
988102 Nebraska Medical Ctr
Omaha, NE, 68198
Phone (402) 559-5600
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
795 services
Medicare patients, 2024
216
Average age 72
Drug cost, 2024
$5.4M
1,666 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lori J Maness-Harris was code 99232 (hospital e&m - subsequent), 332 times for 71 patients. In total Lori J Maness-Harris billed 795 services in 13 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 332 | 71 | $57.05 | $19K |
| 99214 Office E&M - Established | Facility | 270 | 110 | $64.02 | $17K |
| 99214 Office E&M - Established | Office | 60 | 38 | $62.71 | $3,763 |
| 99215 Office E&M - Established | Facility | 39 | 27 | $100.31 | $3,912 |
| 99222 Hospital E&M - Initial | Facility | 34 | 28 | $94.49 | $3,213 |
| 99213 Office E&M - Established | Facility | 17 | 11 | $45.29 | $770 |
| 99239 Hospital Discharge Management | Facility | 15 | 14 | $83.44 | $1,252 |
| 99205 Office E&M - New | Facility | 15 | 15 | $122.48 | $1,837 |
By year: 2022 $49K for 760 services; 2023 $49K for 726 services; 2024 $52K for 795 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lori J Maness-Harris prescribed most often to Medicare patients was Acyclovir, with 131 prescriptions and refills. In total Lori J Maness-Harris wrote 1,666 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 131 | 251 | 36 | $1,754 |
| Tasigna Nilotinib Hcl | 106 | 115 | Under 11 | $1.3M |
| Hydroxyurea Generic | 86 | 167 | 20 | $1,819 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 81 | 152 | 25 | $722 |
| Venclexta Venetoclax | 76 | 76 | 15 | $64K |
| Eliquis Apixaban | 59 | 76 | 12 | $40K |
| Imatinib Mesylate Generic | 58 | 58 | Under 11 | $5,881 |
| Allopurinol Generic | 50 | 103 | 18 | $477 |
| Pantoprazole Sodium Generic | 48 | 70 | Under 11 | $221 |
| Bosulif Bosutinib | 44 | 44 | Under 11 | $637K |
| Jakafi Ruxolitinib Phosphate | 42 | 42 | Under 11 | $596K |
| Potassium Chloride Generic | 37 | 53 | Under 11 | $886 |
| Besremi Ropeginterferon Alfa-2b-Njft | 36 | 36 | Under 11 | $574K |
| Promacta Eltrombopag Olamine | 36 | 36 | Under 11 | $448K |
| Omeprazole Generic | 29 | 57 | Under 11 | $229 |
Brand drugs: - claims; generic drugs: 1,039 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lori J Maness-Harris $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.